# Drug Interaction Study Between Dorzagliatin and Sitagliptin

> **NCT03790839** · PHASE1 · COMPLETED · sponsor: **Hua Medicine Limited** · enrollment: 15 (actual)

## Conditions studied

- Patients

## Interventions

- **DRUG:** Sitagliptin
- **DRUG:** Dorzagliatin

## Key facts

- **NCT ID:** NCT03790839
- **Lead sponsor:** Hua Medicine Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-01-31
- **Primary completion:** 2019-08-30
- **Final completion:** 2019-08-30
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2023-02-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03790839

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03790839, "Drug Interaction Study Between Dorzagliatin and Sitagliptin". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03790839. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*